Not applicableActive Not RecruitingNCT06396611What this trial is testingExercise As Intervention in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Universidade do Porto 11
Testing effectiveness (Phase 2)Looking for participantsNCT07154264What this trial is testingDZD8586 Combination in CLL/SLL (TAI-SHAN10)Who this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Dizal Pharmaceuticals 66
Testing effectiveness (Phase 2)UnknownNCT04827004What this trial is testingAnlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Not applicableStudy completedNCT02080884What this trial is testingAn Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 150
Testing effectiveness (Phase 2)Ended earlyNCT02378038What this trial is testingPNT2258 for Treatment of Patients With Richter's Transformation (Brighton)Who this might be right forRichter's Transformation Sierra Oncology LLC - a GSK company 5
Testing effectiveness (Phase 2)Study completedNCT01523834What this trial is testingOral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCTWho this might be right forDiffuse Large B-cell Lymphoma Fondazione Italiana Linfomi - ETS 35
Large-scale testing (Phase 3)Ended earlyNCT04745832What this trial is testingPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Who this might be right forFollicular Lymphoma (FL)Non Hodgkin LymphomaMarginal Zone Lymphoma MEI Pharma, Inc. 82
Early research (Phase 1)UnknownNCT03840317What this trial is testingSenl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617What this trial is testingLaboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic LeukemiaWho this might be right forCD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more Fred Hutchinson Cancer Center 204
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Testing effectiveness (Phase 2)UnknownNCT01016990What this trial is testingValproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Auxilio Mutuo Cancer Center 52
Large-scale testing (Phase 3)Active Not RecruitingNCT03984448What this trial is testingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasWho this might be right forDiffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble-Expressor Lymphoma+5 more National Cancer Institute (NCI) 363
Very early researchStudy completedNCT01760226What this trial is testingDose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesWho this might be right forDiffuse Large B Cell LymphomaPost Transplant Lymphoproliferative DisorderPrimary Mediastinal (Thymic) Large B-cell Lymphoma Baylor College of Medicine 4
Early research (Phase 1)Looking for participantsNCT07020533What this trial is testingA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more City of Hope Medical Center 46
Testing effectiveness (Phase 2)WithdrawnNCT05571540What this trial is testingAnti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-ALL Kunming Hope of Health Hospital
Testing effectiveness (Phase 2)Ended earlyNCT04676360What this trial is testingBelantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell LymphomaWho this might be right forRelapsed Plasmablastic LymphomaRefractory Plasmablastic LymphomaAnaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma Jacob Soumerai, MD 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238What this trial is testingSequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLLWho this might be right forChronic Lymphoid Leukemia German CLL Study Group 42
Early research (Phase 1)Study completedNCT02945215What this trial is testingAssess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma PatientsWho this might be right forB-Cell Lymphoma Innovent Biologics (Suzhou) Co. Ltd. 181
Testing effectiveness (Phase 2)WithdrawnNCT03187691What this trial is testingSafety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic LeukaemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Matinas BioPharma Nanotechnologies, Inc.
Early research (Phase 1)WithdrawnNCT05934097What this trial is testingFT596 in Combination With R-CHOP in Subjects With B-Cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaTransformed Indolent Non-Hodgkin's LymphomaFollicular Lymphoma+2 more Fate Therapeutics